{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,4,25]],"date-time":"2025-04-25T04:08:54Z","timestamp":1745554134937,"version":"3.40.4"},"reference-count":29,"publisher":"Springer Science and Business Media LLC","issue":"12","license":[{"start":{"date-parts":[[2012,12,1]],"date-time":"2012-12-01T00:00:00Z","timestamp":1354320000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Arch. Pharm. Res."],"published-print":{"date-parts":[[2012,12]]},"DOI":"10.1007\/s12272-012-1217-1","type":"journal-article","created":{"date-parts":[[2012,12,20]],"date-time":"2012-12-20T11:19:27Z","timestamp":1356002367000},"page":"2191-2198","source":"Crossref","is-referenced-by-count":6,"title":["Anti-platelet activity of diacetylated obovatol through regulating cyclooxygenase and lipoxygenase activities"],"prefix":"10.1007","volume":"35","author":[{"given":"Ji-Yeon","family":"Yu","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jung-Jin","family":"Lee","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jae-Kyung","family":"Jung","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yong-Ki","family":"Min","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jin Yeul","family":"Ma","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tack-Joong","family":"Kim","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mi-Yea","family":"Lee","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yeo-Pyo","family":"Yun","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2012,12,21]]},"reference":[{"key":"1217_CR1","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1016\/0922-4106(95)90075-6","volume":"291","author":"S. Akiba","year":"1995","unstructured":"Akiba, S., Nagatomo, R., Ishimoto, T., and Sato, T., Effect of berbamine on cytosolic phospholipase A2 activation in rabbit platelets. Eur. J. Pharmacol., 291, 343\u2013350 (1995).","journal-title":"Eur. J. Pharmacol."},{"key":"1217_CR2","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1113\/jphysiol.1963.sp007185","volume":"168","author":"G. V. Born","year":"1963","unstructured":"Born, G. V. and Cross, M. J., The aggregation of blood platelets. J. Physiol., 168, 178\u2013195 (1963).","journal-title":"J. Physiol."},{"key":"1217_CR3","doi-asserted-by":"crossref","first-page":"18S","DOI":"10.1378\/chest.124.3_suppl.18S","volume":"124","author":"L. F. Brass","year":"2003","unstructured":"Brass, L. F., Thrombin and platelet activation. Chest, 124, 18S\u201325S (2003).","journal-title":"Chest"},{"key":"1217_CR4","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1007\/BF01307189","volume":"11","author":"Y. Q. Chen","year":"1992","unstructured":"Chen, Y. Q., Liu, B., Tang, D. G., and Honn, K. V., Fatty acid modulation of tumor cell-platelet-vessel wall interaction. Cancer Metastasis Rev., 11, 389\u2013409 (1992).","journal-title":"Cancer Metastasis Rev."},{"key":"1217_CR5","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/0021-9150(86)90088-2","volume":"60","author":"A. R. Eynard","year":"1986","unstructured":"Eynard, A. R., Tremoli, E., Caruso, D., Magni, F., Sirtori, C. R., and Galli, G., Platelet formation of 12-hydroxyeicosatetraenoic acid and thromboxane B2 is increased in type IIA hypercholesterolemic subjects. Atherosclerosis, 60, 61\u201366 (1986).","journal-title":"Atherosclerosis"},{"key":"1217_CR6","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1161\/01.CIR.87.2.659","volume":"87","author":"V. Fuster","year":"1993","unstructured":"Fuster, V., Dyken, M. L., Vokonas, P. S., and Hennekens, C., Aspirin as a therapeutic agent in cardiovascular disease. Circulation, 87, 659\u2013675 (1993).","journal-title":"Circulation"},{"key":"1217_CR7","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1254\/jphs.FP0060605","volume":"102","author":"B. Gabryel","year":"2006","unstructured":"Gabryel, B., Chalimoniuk, M., Stolecka, A., Waniek, K., Langfort, J., and Malecki, A., Inhibition of arachidonic acid release by cytosolic phospholipase A2 is involved in the antiapoptotic effect of FK506 and cyclosporin a on astrocytes exposed to simulated ischemia in vitro. J. Pharmacol. Sci., 102, 77\u201387 (2006).","journal-title":"J. Pharmacol. Sci."},{"key":"1217_CR8","doi-asserted-by":"crossref","first-page":"3415","DOI":"10.1242\/jcs.01325","volume":"117","author":"J. M. Gibbins","year":"2004","unstructured":"Gibbins, J. M., Platelet adhesion signalling and the regulation of thrombus formation. J. Cell Sci., 117, 3415\u20133425 (2004).","journal-title":"J. Cell Sci."},{"key":"1217_CR9","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1124\/jpet.104.073718","volume":"312","author":"Y. R. Jin","year":"2005","unstructured":"Jin, Y. R., Cho, M. R., Ryu, C. K., Chung, J. H., Yuk, D. Y., Hong, J. T., Lee, K. S., Lee, J. J., Lee, M. Y., Lim, Y., and Yun, Y. P., Antiplatelet activity of J78 (2-Chloro-3-[2\u2032-bromo, 4\u2032-fluoro-phenyl]-amino-8-hydroxy-1,4-naphthoquinone), an antithrombotic agent, is mediated by thromboxane (TX) A2 receptor blockade with TXA2 synthase inhibition and suppression of cytosolic Ca2+ mobilization. J. Pharmacol. Exp. Ther., 312, 214\u2013219 (2005).","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"1217_CR10","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1016\/j.atherosclerosis.2006.10.011","volume":"194","author":"Y. R. Jin","year":"2007","unstructured":"Jin, Y. R., Han, X. H., Zhang, Y. H., Lee, J. J., Lim, Y., Chung, J. H., and Yun, Y. P., Antiplatelet activity of hesperetin, a bioflavonoid, is mainly mediated by inhibition of PLCgamma2 phosphorylation and cyclooxygenase-1 activity. Atherosclerosis, 194, 144\u2013152 (2007).","journal-title":"Atherosclerosis"},{"key":"1217_CR11","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1002\/jcp.21533","volume":"217","author":"C. Jonnakuty","year":"2008","unstructured":"Jonnakuty, C. and Gragnoli, C., What do we know about serotonin? J. Cell. Physiol., 217, 301\u2013306 (2008).","journal-title":"J. Cell. Physiol."},{"key":"1217_CR12","doi-asserted-by":"crossref","first-page":"1107","DOI":"10.1007\/s12272-011-0708-9","volume":"34","author":"J. H. Kwak","year":"2011","unstructured":"Kwak, J. H., Lee, S., Park, E. S., In, J. K., Song, J., Kim, Y. J., Choi, N. S., Lee, H., Yun, Y. P., Hong, J. T., Kwak, Y. S., Min, K. H., and Jung, J. K., Synthesis and anti-platelet activity of obovatol derivatives. Arch. Pharm. Res., 34, 1107\u20131112 (2011).","journal-title":"Arch. Pharm. Res."},{"key":"1217_CR13","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1016\/j.atherosclerosis.2009.02.034","volume":"206","author":"J. J. Lee","year":"2009","unstructured":"Lee, J. J., Jin, Y. R., Yu, J. Y., Munkhtsetseg, T., Park, E. S., Lim, Y., Kim, T. J., Pyo, M. Y., Hong, J. T., Yoo, H. S., Kim, Y., and Yun, Y. P., Antithrombotic and antiplatelet activities of fenofibrate, a lipid-lowering drug. Atherosclerosis, 206, 375\u2013382 (2009).","journal-title":"Atherosclerosis"},{"key":"1217_CR14","doi-asserted-by":"crossref","first-page":"1601","DOI":"10.5012\/bkcs.2007.28.9.1601","volume":"28","author":"M. S. Lee","year":"2007","unstructured":"Lee, M. S., Yang, J. E., Choi, E. H., In, J. K., Lee, S. Y., Lee, H. S., Hong, J. T., Lee, H. Y., Suh, Y. G., and Jung, J. K., Synthesis of obovatol derivatives and their preliminary evaluation as antitumor agents. Bull. Korean Chem. Soc., 28, 1601\u20131604 (2007).","journal-title":"Bull. Korean Chem. Soc."},{"key":"1217_CR15","doi-asserted-by":"crossref","first-page":"8397","DOI":"10.1016\/j.bmc.2008.08.033","volume":"16","author":"S. K. Lee","year":"2008","unstructured":"Lee, S. K., Kim, H. N., Kang, Y. R., Lee, C. W., Kim, H. M., Han, D. C., Shin, J., Bae, K., and Kwon, B. M., Obovatol inhibits colorectal cancer growth by inhibiting tumor cell proliferation and inducing apoptosis. Bioorg. Med. Chem., 16, 8397\u20138402 (2008a).","journal-title":"Bioorg. Med. Chem."},{"key":"1217_CR16","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/j.ejphar.2007.12.027","volume":"582","author":"S. Y. Lee","year":"2008","unstructured":"Lee, S. Y., Yuk, D. Y., Song, H. S., Yoon, D. Y., Jung, J. K., Moon, D. C., Lee, B. S., and Hong, J. T., Growth inhibitory effects of obovatol through induction of apoptotic cell death in prostate and colon cancer by blocking of NFkappaB. Eur. J. Pharmacol., 582, 17\u201325 (2008b).","journal-title":"Eur. J. Pharmacol."},{"key":"1217_CR17","doi-asserted-by":"crossref","first-page":"1241","DOI":"10.1345\/aph.10381","volume":"35","author":"A. Majid","year":"2001","unstructured":"Majid, A., Delanty, N., and Kantor, J., Antiplatelet agents for secondary prevention of ischemic stroke. Ann. Pharmacother., 35, 1241\u20131247 (2001).","journal-title":"Ann. Pharmacother."},{"key":"1217_CR18","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/S0049-3848(98)00097-8","volume":"92","author":"A. McNicol","year":"1998","unstructured":"McNicol, A. and Shibou, T. S., Translocation and phosphorylation of cytosolic phospholipase A2 in activated platelets. Thromb. Res., 92, 19\u201326 (1998).","journal-title":"Thromb. Res."},{"key":"1217_CR19","doi-asserted-by":"crossref","first-page":"866","DOI":"10.1016\/0006-291X(83)91697-2","volume":"112","author":"J. Nakao","year":"1983","unstructured":"Nakao, J., Ito, H., Chang, W. C., Koshihara, Y., and Murota, S., Aortic smooth muscle cell migration caused by plateletderived growth factor is mediated by lipoxygenase product(s) of arachidonic acid. Biochem. Biophys. Res. Commun., 112, 866\u2013871 (1983).","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"1217_CR20","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1016\/0021-9150(82)90018-1","volume":"43","author":"J. Nakao","year":"1982","unstructured":"Nakao, J., Ooyama, T., Chang, W. C., Murota, S., and Orimo, H., Platelets stimulate aortic smooth muscle cell migration in vitro. Involvement of 12-L-hydroxy-5,8,10,14-eicosatetraenoic acid. Atherosclerosis, 43, 143\u2013150 (1982).","journal-title":"Atherosclerosis"},{"key":"1217_CR21","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1146\/annurev.bi.55.070186.000441","volume":"55","author":"P. Needleman","year":"1986","unstructured":"Needleman, P., Turk, J., Jakschik, B. A., Morrison, A. R., and Lefkowith, J. B., Arachidonic acid metabolism. Annu. Rev. Biochem., 55, 69\u2013102 (1986).","journal-title":"Annu. Rev. Biochem."},{"key":"1217_CR22","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1016\/S0022-3565(25)20629-2","volume":"278","author":"M. D. Nyby","year":"1996","unstructured":"Nyby, M. D., Sasaki, M., Ideguchi, Y., Wynne, H. E., Hori, M. T., Berger, M. E., Golub, M. S., Brickman, A. S., and Tuck, M. L., Platelet lipoxygenase inhibitors attenuate thrombinand thromboxane mimetic-induced intracellular calcium mobilization and platelet aggregation. J. Pharmacol. Exp. Ther., 278, 503\u2013509 (1996).","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"1217_CR23","doi-asserted-by":"crossref","first-page":"659","DOI":"10.5551\/jat.7427","volume":"18","author":"E. S. Park","year":"2011","unstructured":"Park, E. S., Lim, Y., Lee, S. H., Kwon, B. M., Yoo, H. S., Hong, J. T., and Yun, Y. P., Antiplatelet activity of obovatol, a biphenolic component of Magnolia obovata, in rat arterial thrombosis and rabbit platelet aggregation. J. Atheroscler. Thromb., 18, 659\u2013669 (2011).","journal-title":"J. Atheroscler. Thromb."},{"key":"1217_CR24","doi-asserted-by":"crossref","first-page":"866","DOI":"10.1042\/bj2350869","volume":"235","author":"W. K. Pollock","year":"1986","unstructured":"Pollock, W. K., Rink, T. J., and Irvine, R. F., Liberation of [3H]arachidonic acid and changes in cytosolic free calcium in fura-2-loaded human platelets stimulated by ionomycin and collagen. Biochem. J., 235, 866\u2013877 (1986).","journal-title":"Biochem. J."},{"key":"1217_CR25","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1016\/0005-2760(87)90096-8","volume":"920","author":"A. D. Purdon","year":"1987","unstructured":"Purdon, A. D., Patelunas, D., and Smith, J. B., Evidence for the release of arachidonic acid through the selective action of phospholipase A2 in thrombin-stimulated human platelets. Biochim. Biophys. Acta, 920, 205\u2013214 (1987).","journal-title":"Biochim. Biophys. Acta"},{"key":"1217_CR26","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1007\/BF01952188","volume":"44","author":"T. J. Rink","year":"1988","unstructured":"Rink, T. J., Cytosolic calcium in platelet activation. Experientia, 44, 97\u2013100 (1988).","journal-title":"Experientia"},{"key":"1217_CR27","doi-asserted-by":"crossref","first-page":"1227","DOI":"10.1038\/nm1102-1227","volume":"8","author":"Z. M. Ruggeri","year":"2002","unstructured":"Ruggeri, Z. M., Platelets in atherothrombosis. Nat. Med., 8, 1227\u20131234 (2002).","journal-title":"Nat. Med."},{"key":"1217_CR28","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1254\/jphs.FP0040574","volume":"97","author":"T. Seki","year":"2005","unstructured":"Seki, T., Ishimoto, T., Sakurai, T., Yasuda, Y., Taniguchi, K., Doi, M., Sato, M., Roman, R. J., and Miyata, N., Increased excretion of urinary 20-HETE in rats with cyclosporineinduced nephrotoxicity J. Pharmacol. Sci., 97, 132\u2013137 (2005).","journal-title":"J. Pharmacol. Sci."},{"key":"1217_CR29","first-page":"431","volume":"73","author":"E. J. Wasserman","year":"2006","unstructured":"Wasserman, E. J. and Shipley, N. M., Atherothrombosis in acute coronary syndromes: mechanisms, markers, and mediators of vulnerability. Mt. Sinai J. Med., 73, 431\u2013439 (2006).","journal-title":"Mt. Sinai J. Med."}],"container-title":["Archives of Pharmacal Research"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12272-012-1217-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s12272-012-1217-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12272-012-1217-1","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,4,24]],"date-time":"2025-04-24T03:05:55Z","timestamp":1745463955000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s12272-012-1217-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,12]]},"references-count":29,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2012,12]]}},"alternative-id":["1217"],"URL":"https:\/\/doi.org\/10.1007\/s12272-012-1217-1","relation":{},"ISSN":["0253-6269","1976-3786"],"issn-type":[{"type":"print","value":"0253-6269"},{"type":"electronic","value":"1976-3786"}],"subject":[],"published":{"date-parts":[[2012,12]]}}}